Compile Data Set for Download or QSAR
maximum 50k data
Found 37 Enz. Inhib. hit(s) with all data for entry = 50021381
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224024(6-(4-(2-((S)-2-hydroxy-3-(3-isobutyl-2-oxoindolin-...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224030(6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...)
Affinity DataEC50:  58nMAssay Description:Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224031(6-(4-(2-((S)-2-hydroxy-3-(3-isopropyl-2-oxoindolin...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224021((S)-6-(4-(2-(3-(3,3-dimethyl-2-oxoindolin-4-yloxy)...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224029(6-(4-(2-((S)-3-(3-benzyl-2-oxoindolin-4-yloxy)-2-h...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224026((S)-6-(4-(2-(2-hydroxy-3-(2-oxoindolin-4-yloxy)pro...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224025(6-(4-(2-((S)-2-hydroxy-3-(3-methyl-2-oxoindolin-4-...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224027((S)-6-(4-(2-(3-(3,3-dibenzyl-2-oxoindolin-4-yloxy)...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224022(6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224023((S)-6-(4-(2-(3-(3,3-diethyl-2-oxoindolin-4-yloxy)-...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224028(6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224032(6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224023((S)-6-(4-(2-(3-(3,3-diethyl-2-oxoindolin-4-yloxy)-...)
Affinity DataEC50:  2.70nMAssay Description:Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224025(6-(4-(2-((S)-2-hydroxy-3-(3-methyl-2-oxoindolin-4-...)
Affinity DataEC50:  12nMAssay Description:Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224024(6-(4-(2-((S)-2-hydroxy-3-(3-isobutyl-2-oxoindolin-...)
Affinity DataEC50:  14nMAssay Description:Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224027((S)-6-(4-(2-(3-(3,3-dibenzyl-2-oxoindolin-4-yloxy)...)
Affinity DataEC50:  268nMAssay Description:Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224024(6-(4-(2-((S)-2-hydroxy-3-(3-isobutyl-2-oxoindolin-...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224029(6-(4-(2-((S)-3-(3-benzyl-2-oxoindolin-4-yloxy)-2-h...)
Affinity DataEC50:  12nMAssay Description:Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224030(6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...)
Affinity DataEC50:  6.60nMAssay Description:Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224022(6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224031(6-(4-(2-((S)-2-hydroxy-3-(3-isopropyl-2-oxoindolin...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224022(6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...)
Affinity DataEC50:  8.30nMAssay Description:Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224031(6-(4-(2-((S)-2-hydroxy-3-(3-isopropyl-2-oxoindolin...)
Affinity DataEC50:  14nMAssay Description:Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224021((S)-6-(4-(2-(3-(3,3-dimethyl-2-oxoindolin-4-yloxy)...)
Affinity DataEC50:  5.20nMAssay Description:Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224026((S)-6-(4-(2-(2-hydroxy-3-(2-oxoindolin-4-yloxy)pro...)
Affinity DataEC50:  24nMAssay Description:Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224023((S)-6-(4-(2-(3-(3,3-diethyl-2-oxoindolin-4-yloxy)-...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224025(6-(4-(2-((S)-2-hydroxy-3-(3-methyl-2-oxoindolin-4-...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224032(6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...)
Affinity DataEC50:  11nMAssay Description:Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224027((S)-6-(4-(2-(3-(3,3-dibenzyl-2-oxoindolin-4-yloxy)...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224026((S)-6-(4-(2-(2-hydroxy-3-(2-oxoindolin-4-yloxy)pro...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224032(6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224021((S)-6-(4-(2-(3-(3,3-dimethyl-2-oxoindolin-4-yloxy)...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224028(6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Rattus norvegicus)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224021((S)-6-(4-(2-(3-(3,3-dimethyl-2-oxoindolin-4-yloxy)...)
Affinity DataEC50:  6.5nMAssay Description:Agonist activity at rat beta-3 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224028(6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...)
Affinity DataEC50:  18nMAssay Description:Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224029(6-(4-(2-((S)-3-(3-benzyl-2-oxoindolin-4-yloxy)-2-h...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50224030(6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...)
Affinity DataEC50:  35nMAssay Description:Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed